Karyopharm Therapeutics (KPTI) Short term Debt (2025 - 2026)
Karyopharm Therapeutics (KPTI) posted Short term Debt of $40.31 million for Q2 2026, up 544.9% from $6.25 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Short term Debt (2025 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Short term Debt came in at $21.01 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Karyopharm Therapeutics | 766,856.99 | -264.81 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.31 Mn |
| Dec 31, 2025 | 21.01 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Jun 30, 2025 | 6.25 Mn |
API Access
Karyopharm Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();